JBIONasdaq

Jade Biosciences, Inc.

Alert me on JBIO

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for JBIO

31 held · newest 531 held · newest 2

Loading the filings.

See all 31 filings for JBIO

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Sep 30, 2026 Schedule 13G

Franklin Templeton, Inc.: 6%, 3,807,236 shares

Sep 30, 2026 Schedule 13G

BlackRock, Inc.: 5.2%, 3,323,301 shares

Jun 30, 2026 Schedule 13G, amended

Venrock Healthcare Capital Partners III, L.P.: 8.3%, 5,145,330 shares

Jun 30, 2026 Schedule 13G, amended

Bellevue Group AG: 5%, 3,057,996 shares

Jul 10, 2026 Schedule 13G

Paradigm BioCapital Advisors LP: 5.1%, 3,106,793 shares

Jun 30, 2026 Schedule 13G, amended

JANUS HENDERSON GROUP Ltd.: 10.6%, 6,273,262 shares

Jun 5, 2026 Schedule 13D, amended

Fairmount Funds Management LLC: 20%, 14,069,494 shares

Mar 31, 2026 Schedule 13G, amended

JANUS HENDERSON GROUP PLC: 6.3%, 3,105,669 shares

Mar 31, 2026 Schedule 13G, amended

BlackRock, Inc.: 4.7%, 2,295,825 shares

Apr 28, 2025 Schedule 13D, amended

Sofinnova Venture Partners X, L.P. ("SVP X"): 0.3%, 107,391 shares

Dec 31, 2025 Schedule 13G, amended

Venrock Healthcare Capital Partners III, L.P.: 9.9%, 5,115,862 shares

Dec 16, 2025 Schedule 13G

Bellevue Group AG: 6.8%, 3,341,103 shares

Dec 31, 2025 Schedule 13G

JANUS HENDERSON GROUP PLC: 6.2%, 3,063,457 shares

Dec 31, 2025 Schedule 13G, amended

Deep Track Capital, LP: 0%, 0 shares

Dec 31, 2025 Schedule 13G, amended

The Vanguard Group: 4.2%, 2,095,767 shares

Sep 30, 2025 Schedule 13G, amended

Frazier Life Sciences Public Fund, L.P.: 4.2%, 1,384,646 shares

Sep 30, 2025 Schedule 13G, amended

Deep Track Capital, LP: 7%, 2,279,892 shares

Sep 30, 2025 Schedule 13G, amended

BlackRock, Inc.: 6.6%, 2,150,203 shares

Oct 8, 2025 Schedule 13G

RA Capital Management, L.P.: 7%, 3,214,969 shares

Oct 6, 2025 Schedule 13D, amended

Fairmount Funds Management LLC: 20%, 10,353,875 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.